Physician profile
Gary J Millward
NPI 1063462075
$6,586.78
in general payments reported to CMS, 2019-2025
11 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $3,000 · 2021: $1,117 · 2022: $1,557 · 2023: $220 · 2024: $314 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $4,009.30 | 2019-2021 | |
| Steelhead Surgical INC | $1,476.85 | 2022 | |
| Ossio INC | $249.99 | 2024 | |
| Stryker Corporation | $221.89 | 2019-2025 | Citrefix |
| Depuy Synthes Sales INC. | $201.26 | 2023-2025 | Motoband |
| Boston Scientific Corporation | $158.78 | 2019-2023 | |
| Treace Medical Concepts, INC. | $137.64 | 2021-2022 | |
| Trimed, INC. | $59.40 | 2022 | |
| Nevro Corp. | $36.04 | 2023 | Senza |
| Medline Industries LP | $19.69 | 2025 | |
| Horizon Therapeutics Plc | $15.94 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Millward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.